PTGS2 dimer oxidises DHA to 13-HDHA

Stable Identifier
Reaction [transition]
Homo sapiens
Locations in the PathwayBrowser
SVG |   | PPTX  | SBGN
Click the image above or here to open this reaction in the Pathway Browser
The layout of this reaction may differ from that in the pathway view due to the constraints in pathway layout

In the absence of aspirin, dimeric cyclooxygenase 2 (PTGS2 aka COX2) located on the ER membrane can mediate the oxidation of docosahexaenoic acid (DHA) to 13-hydroxy-docosahexaenoic acid (13-HDHA) in activated macrophages (Serhan et al. 2002, Groeger et al. 2010). PTGS2 is an inducible enzyme expressed at sites of inflammation, infection and cancer where it can generate prostanoids that drive disease pathogenesis. It is the therapeutic target for nonsteroidal antiinflammatory drugs (NSAIDs) such as aspirin. PTGS2 is also constitutively expressed in specific tissues, especially the kidney, gastrointestinal tract, brain and thymus. Constitutive PTGS2 expression is increasingly being recognised to play a major role in homeostatic function in those tissues and is therapeutically important because NSAIDs cause cardiovascular and renal side effects in otherwise healthy individuals (Kirkby et al. 2016).

Literature References
PubMed ID Title Journal Year
12391014 Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals

Gronert, K, Serhan, CN, Devchand, PR, Colgan, SP, Hong, S, Mirick, G, Moussignac, RL

J. Exp. Med. 2002
20436486 Cyclooxygenase-2 generates anti-inflammatory mediators from omega-3 fatty acids

Cipollina, C, Schopfer, FJ, Cole, MP, Rudolph, V, Freeman, BA, Groeger, AL, Rudolph, TK, Bonacci, G, Woodcock, SR

Nat. Chem. Biol. 2010
Catalyst Activity

arachidonate 15-lipoxygenase activity of PTGS2 dimer [endoplasmic reticulum membrane]

Orthologous Events
Cite Us!